Symbolic image of Coronavirus Vaccine

How the Oxford Vaccine will Fight Against Coronavirus

The University of Oxford has developed a vaccine that is relatively fast in preventing coronavirus. In the meantime, it has reached the final stage of experimental application. Preliminary results of the experimental application of the vaccine were released on Monday. That said, the Oxford vaccine seems to be safe for human application. However, more testing is needed to find out about its side effects.

According to the BBC, preliminary results show that the Oxford vaccine helps in the production of antibodies and white blood cells in the human body. This allows the body's immune system to understand the strategy to fight the new coronavirus.

Scientists say the study found evidence of an increase in white blood cells in the human body 14 days after the Oxford vaccine was administered. And after 28 days of vaccination, antibodies are increasing. However, it is not clear how long these increased antibodies and white blood cells last in the human body. Because, this requires experimental application of the vaccine on a larger scale.

"We are really pleased with the results released today," said Andrew Pollard, a professor at the Oxford Research Group. This result is very promising and we think that this response is related to protection from corona.

The results, published in The Lancet, show that about 90 percent of people develop antibodies after using a single dose of the Oxford vaccine. In the remaining 10 percent of cases, two doses of the antibody are needed. Professor Pollard says, ‘We don’t know exactly how much antibody is needed for full protection. However, by giving the second dose, that level of antibody can be taken to the maximum.

Based on preliminary results, the researchers say, the Oxford vaccine is safe. However, it has side effects. Of course, those side effects are not dangerous. In people who have been experimentally applied, 60 percent have experienced a fever or headache later in life. These side effects have been treated with ordinary paracetamol.

However, experts say that although the vaccine may seem promising at first, further testing is needed before the vaccine can be made available to the public. The vaccine prevents or reduces the symptoms of Covid-19 disease — preliminary results do not prove this.

In the second phase of the trial, 10,000 people in the UK will be vaccinated with the Oxford vaccine. The vaccine will be tested on 30,000 people in the United States, 2,000 in South Africa and 5,000 in Brazil. Then there is a step called 'Challenge Trial'. Some people who get vaccinated at that stage will be willingly infected with the new coronavirus. However, there are some moral restrictions in that case.

Basically, the Oxford vaccine will be allowed to come on the market after going through so many steps. It is hoped that the vaccine will be released to the public by the end of this year. However, in that case, health workers will get priority. Then gradually it will be available worldwide. Experts speculate that the vaccine could be available worldwide as early as next year. However, there is a condition in that case. That is, it will only be possible if all the processes are done properly.

Related Searches

• coronavirus vaccine update
• latest vaccine update of coronvirus
• coronavirus vaccine latest news
• covid-19 vaccine update
• oxford vaccine update of covid-19
• vaccine update
• covid-19 vaccine
• American coronavirus update
• coronavirus update usa
• latest update of coronvirus
• coronavirus latest news usa
• usa covid-19 update
• How the Oxford Vaccine will Fight Against Coronavirus